Curis, Inc., a biotechnology company, focuses on the development and commercialization of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CUDC-907, an oral dual inhibitor of HDAC and PI3K enzymes, which is in Phase II clinical trial for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors; CA-170, an oral small molecule drug candidate that is in Phase I clinical trial for treating patients with advanced solid tumors and lymphomas; CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas; and CA-327, an oral small molecule drug candidate that is in preclinical stage for the treatment of cancers. The company has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma; and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. Curis, Inc. was founded in 2000 and is headquartered in Lexington, Massachusetts.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [07/17/2019 21:21 PDT] Market Maker Surveillance Report. CRIS, Losing Stocks With Lowest Price Friction For Wednesday, July 17th 2019
• [07/15/2019 07:49 PDT] CRIS Expected to Trade Up After Bullish Patterns Develop
• [07/11/2019 10:30 PDT] Curis, Inc. (NASDAQ:CRIS), Up By 100.00% ($1.83) After BUYINS.NET SqueezeTrigger Report Released on Wednesday, June 26th 2019 at a Price of $1.830.
• [07/11/2019 10:30 PDT] Curis, Inc. (NASDAQ:CRIS), Up By 100.00% ($1.84) After BUYINS.NET SqueezeTrigger Report Released on Monday, July 8th 2019 at a Price of $1.840.
• [07/08/2019 10:29 PDT] CRIS SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/26/2019 13:20 PDT] CRIS SqueezeTrigger Price is $0.00. There is $0 That Short Sellers Still Need To Cover.
• [06/24/2019 06:54 PDT] CRIS Expected to Trade Down After Bearish Patterns Develop
• [06/19/2019 09:25 PDT] CRIS Expected to Trade Up After Bullish Patterns Develop
• [05/29/2019 07:32 PDT] CRIS Expected to Trade Down After Bearish Patterns Develop
• [05/22/2019 09:24 PDT] CRIS Expected to Trade Up After Bullish Patterns Develop